Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

SARcode Corporation is a private San Francisco based biopharmaceutical company engaged in the development of a novel class of small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; αLβ2) antagonists as a topical agent for the treatment of significant unmet medical needs in ophthalmology, dermatology and other inflammatory diseases.

Asahi Kasei Medical Co. Ltd. engages in the development, manufacture and sale of medical devices. It also engages in the development, manufacture and sale of dialyzers, therapeutic apheresis products, leukocyte reduction filters and virus removal filters. The company was founded on July 24, 1974 and is headquartered in Tokyo, Japan.

Bracco International BV wholesales and distributes pharmaceutical products. It engages in the promotion and marketing of products manufactured by Bracco SpA across the world. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands.

Psimei Pharmaceuticals Ltd. develops pharmaceutical products. It provides radiation therapy and treatment of cancer cells using a technique called Photon Activation Therapy. The company is headquartered in Bramley, the United Kingdom.

Syntonix discovers and develops novel, long-acting, proprietary therapeutic products using the company’s proprietary Fc-fusion proteins and other engineered ligands which bind to specific Fc receptors. These technologies, including Syntonix’ drug delivery platform technology Transceptor™, harness the body’s natural pathways for protecting antibodies against premature destruction and for transporting antibodies across cell barriers such as those in the lungs and intestines. Syntonix focuses on using these technologies to create next generation treatments for devastating chronic diseases such as hemophilia, anemia, and autoimmune disorders. Syntonix develops selected products for specialty indications, such as hemophilia, on its own. Other products will be evaluated and commercialized through partnerships with companies with established market positions. The company is headed by an experienced management team and has focused initially on using its proprietary technology to enhance existing drugs with proven safety, efficacy, and economic return. Syntonix currently occupies a 25,000 square foot state-of-the-art laboratory facility, including a cGMP clinical manufacturing suite, in Waltham, Massachusetts.

Develops and manufactures drugs related to immunology, neurobiology and oncology

Beijing Juete Biotechnology Co., Ltd., established on 2011-09-22, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:pharmaceutical production;Drug retail;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.

NUCTECH Co. Ltd. researches and develops security inspection technology. The company offers products such as cargo & vehicle inspection systems, mail sterilization systems, radioactivity monitors, X-Ray inspection systems and industrial CT. Its products are used in the fields, including customs, railway security, aviation security, industrial manufacturing, medical devices, environmental protection and food processing. NUCTECH was founded in 1997 and is headquartered in Beijing, China

Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates. It specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its suite of nanotechnology platforms. Ascendia formulates products for injectable, oral, and topical routes of administration. The company has three technology platforms - EmulSol for producing nano-emulsions, AmorSol for creating amorphous solid dispersions, and NanoSol for formulating nano-particles.

Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.

Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Nanjing Anji Biotechnology Co., Ltd., established on 2012-04-12, Business scope includes licensed projects:Drug retail;Veterinary drug business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.

FUJIFILM Manufacturing Europe BV, part of FUJIFILM Holdings Corp., is a company headquartered in Tilburg, the Netherlands, that manufactures photo paper, offset plates and membranes products.

Kunming Space Water Technology Engineering Co., Ltd., established on 1994-06-28, Business scope includes water treatment equipment,air purification equipment,Biological and medical equipment(branch only),Instrumentation equipment,Development of Electronic Appliances,Research,design,Install,Supporting processing and production;Wujinjiaodian,architecture,decorative material,Minerals,Agricultural and sideline products,Daily Chemicals,sales of cosmetics(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hubei Shendi Biotechnology Co., Ltd., established on 2008-03-11, Business scope includes biotechnology development,Acquisition of agricultural products(Does not contain grain),Deep Processing;Production of agricultural by-products,processing,Sales;cosmetic,daily necessities,Pre-packaged food,dairy products(Does not contain infant formula),food grade ingredients,Pharmaceutical Grade Ingredients,Research and development of powdered egg feed,Production,Sales;Cold storage rental,Cargo storage leasing and cargo transportation;"Import and export","Technology Import and Export"and"Agent import and export"(Excludes businesses that are prohibited or restricted from import and export by the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)